Cite
HARVARD Citation
Yang, C. et al. (2007). 96 DYAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING PHARMACODYNAMIC STUDY OF SORAFENIB IN METASTATIC RENAL CELL CARCINOMA: PRELIMINARY RESULTS OF A RANDOMIZED, PHASE II TRIAL.. Journal of investigative medicine. p. S364. [Online].